Business
Coherus Oncology raises USD 50.1m in public offering of common stock
Redwood City, California-based Coherus Oncology, Inc. (NASDAQ: CHRS) announced the pricing of an underwritten Coherus Oncology public offering of common...
Yatiri Bio options global rights to Oscotec's multikinase inhibitor denfivontinib for AML
Yatiri Bio, a San Diego-based precision medicine company, has entered an exclusive global option to in-license agreement with South Korea's Oscotec for...
Shionogi Acquires Apnimed's SASS Joint Venture Stake for USD 150m to Consolidate Sleep Medicine Portfolio
Shionogi & Co., Ltd. has entered a definitive agreement to acquire Apnimed, Inc.'s 50% ownership of the Shionogi-Apnimed Sleep Science, LLC (SASS) joint...
Opus Genetics raises USD 25m in private placement
U.S.-based Opus Genetics (Nasdaq: IRD) announced a USD 25 million private placement financing through the sale of Series B Non-Voting Convertible Preferred...
Ovid Therapeutics raises USD 60m in private placement to expand epilepsy pipeline
Ovid Therapeutics Inc. (Nasdaq: OVID), a New York-based biopharmaceutical company developing small molecule therapies for neurological disorders, announced...
Seaport Therapeutics Receives Up to $15M ARPA-H Award to Advance Lymphatic-Targeted Oral Prodrug
Boston-based Seaport Therapeutics, a clinical-stage company focused on neuropsychiatric medicines, has received a non-dilutive award of up to USD 15 million...
Altesa BioSciences Closes USD 75 Million Series B to Advance Rhinovirus Antiviral Therapy
Altesa BioSciences, a clinical-stage company headquartered in Atlanta focused on developing antiviral therapies for chronic lung disease, has closed an...
Ovid Therapeutics raises USD 60m in private placement
Ovid Therapeutics Inc. (Nasdaq: OVID), a New York-based biopharmaceutical company developing small molecule therapies for brain disorders, announced a USD...
Xenon Pharmaceuticals raises USD 747.5m in upsized public offering
Canada-based Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company with offices in Vancouver and Boston, announced the...
Insilico Medicine and Liquid AI partner on lightweight AI foundation models for drug discovery
Insilico Medicine, a clinical-stage AI-driven drug discovery company headquartered in Hong Kong, and Liquid AI, a Cambridge, Massachusetts-based AI...
Liminatus Pharma raises USD 4m in best-efforts public offering
Cerritos, California-based Liminatus Pharma (NASDAQ: LIMN) announced the pricing of a best-efforts public offering expected to generate approximately USD...
Innovent and Lilly's $8.5B Oncology Deal Sparks Global Cancer Research Collaboration
Innovent and Lilly Forge Strategic Alliance to Advance Global Oncology and Immunology Research
Gilgamesh Pharma Raises USD 60M Series A to Advance Neuropsychiatric Drug Pipeline
Gilgamesh Pharma, a clinical-stage neuroscience company headquartered in New York, has closed an oversubscribed USD 60 million Series A financing round to...
Artelo Biosciences raises USD 11m in private placement
Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company based in Solana Beach, California, announced an Artelo $11 million private...
Excalipoint Therapeutics Closes Oversubscribed $68.7 Million Seed Round for T-Cell Engager Therapies
Excalipoint Therapeutics, a Shanghai-based biotechnology company focused on next-generation T-cell engager therapies for cancer and autoimmune diseases, has...
The AllSci Brief
Systematic R&D and deal news. Daily.